What is Paclitaxel-trastuzumab-pertuzumab (THP)?

Category: Prescription Drugs

false

See also: Paclitaxel Pertuzumab Trastuzumab

Paclitaxel-trastuzumab-pertuzumab, also known as THP, is a regimen that may be used for the treatment of breast cancer. It contains the anticancer agents paclitaxel (Taxol®), trastuzumab (Herceptin®), and pertuzumab (Perjeta®).

Dosages

Based on patients currently taking Paclitaxel-trastuzumab-pertuzumab (THP)

Dosage Patients
weekly 1

Duration

Currently taking Paclitaxel-trastuzumab-pertuzumab (THP)

Duration Patients
1 - 6 months 1

What people switch to and from

Patients started taking Paclitaxel-trastuzumab-pertuzumab (THP) after stopping:

Treatment Patients
Capecitabine (Xeloda) 1
Paclitaxel (Taxol) 1
Last updated:
There are no evaluations for Paclitaxel-trastuzumab-pertuzumab (THP).